<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To determine the effects of duodenogastric juice pH on the development of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EAC) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: An animal model of duodenogastroesophageal reflux was established using Sprague-Dawley (SD) rats undergoing esophagoduodenostomy (ED) </plain></SENT>
<SENT sid="2" pm="."><plain>The development of EAC was investigated in rats exposed to duodenogastric juice of different pH </plain></SENT>
<SENT sid="3" pm="."><plain>The rats were divided into three groups: low-pH group (group A), high-pH group (group B) and a sham-operated group as a control (group C) (n = 30 rats in each group) </plain></SENT>
<SENT sid="4" pm="."><plain>The incidence of <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE), <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and EAC was observed 40 wk after the treatment </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The incidence rate of <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, BE, <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and EAC was higher in groups A and B compared with the control group after 40 wk (P &lt; 0.01), being 96% and 100% (P &gt; 0.05), 88% and 82.4% (P &gt; 0.05), 20% and 52.1% (P &lt; 0.05), and 8% and 39% (P &lt; 0.05), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Non-acidic refluxate increases the occurrence of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and EAC while the low-pH gastric juice exerts a protective effect in the presence of duodenal juice </plain></SENT>
<SENT sid="7" pm="."><plain>The non-<z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> is particularly important in the progression from BE to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, control of <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenal reflux</z:e> may be an important prophylaxis for EAC </plain></SENT>
</text></document>